Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Gene delivery from a DNA controlled-release stent in porcine coronary arteries

Article Abstract:

This report examines angioplasty, the surgical procedure for treating heart disease using expandable intra-arterial stent with controlled dosage of DNA from a drug delivery system. The procedure on pig coronary angioplasty was performed at the University of Pennsylvania Medical Center and Children's Hospital, both in Philadelphia, Pennsylvania.

Author: Klugherz, Bruce D., Jones, Peter L., Cui, Xiumin, Chen, Weiliam, Meneveau, Nicholas F., DeFelice, Suzanne, Connolly, Jeanne, Wilensky, Robert L., Levy, Robert J.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
Production management, Health Care and Social Assistance, Surgical Appliance and Supplies Manufacturing, Surgical Procedures, HEALTH SERVICES, Surgical appliances and supplies, Medical Instruments and Supplies, Genetic Engineering, Surgical and Medical Instrument Manufacturing, Cardiovascular Therapy Equip, Angioplasty Supplies, Surgery, Cardiovascular equipment, Angioplasty devices

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Gene delivery from a DNA controlled-release stent in porcine coronary arteries

Article Abstract:

Researchers believe that local gene delivery could be accomplished with the controlled release of DNA from a polymer coating on an expandable stent.

Author: Klugherz, Bruce D. et al
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
Cardiovascular Preparations, Cardiovascular agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera

Article Abstract:

There is the growing need to develop methods for delivering drugs that can be potentially therapeutic for T-cell-mediated diseases increases. One possible drug delivery system is MHC-peptide complexes that are the sole antigen-specific ligands for the T-cell receptor.

Author: Casares, Sofia, Stan, Alexandru C., Bona, Constantin A.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
Cellular Biology, Cytology

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Drug delivery systems
Similar abstracts:
  • Abstracts: 'Nonqualified deferred com plans' help firms retain key employees. Stock plans reward employees, protect ownership level
  • Abstracts: Engineered antibody fragments and the rise of single domains. Proteins emerge from disarray
  • Abstracts: The development of secondary market liquidity for NYSE-listed IPOs. Order flow and liquidity aruond NYSE trading halls
  • Abstracts: Incentives versus standards: properties of accounting income in four East Asian countries. The effect of international institutional factors on properties of accounting earnings
  • Abstracts: Charity begins at home: Investors now have the opportunity ot use their Pep to donate money to charity via an online Pep provider
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.